Previous Article | Next Article ![]()
Journal of Virology, June 2001, p. 5498-5503, Vol. 75, No. 12
Plum Island Animal Disease Center, Agricultural Research
Service, U.S. Department of Agriculture, Greenport, New York 11944
Received 21 December 2000/Accepted 20 March 2001
We previously demonstrated that the ability of foot-and-mouth
disease virus (FMDV) to form plaques in cell culture is associated with
the suppression of alpha/beta interferon (IFN- Alpha/beta interferon (IFN- Foot-and-mouth disease virus (FMDV) is a positive-stranded
RNA virus in the family Picornaviridae (22).
Viral RNA is translated into a polyprotein which is co- and
posttranslationally processed by virus-encoded proteinases into mature
viral proteins (22, 25). L proteinase, the first viral
protein to be translated, cleaves itself from the polyprotein at its
carboxy terminus (24). L proteinase also cleaves host
translation initiation factor eIF-4G resulting in the shutoff of host
cap-dependent mRNA translation (7, 10, 13, 15).
Consequently, FMDV RNA, which initiates translation in a
cap-independent fashion via an internal ribosome entry site (IRES) and
does not require intact eIF-4G, can freely use the host protein
synthesis machinery for viral protein production (6, 10, 14, 20,
22).
In a recent study, it was proposed that L proteinase is an FMDV
virulence factor since its cleavage of eIF-4G suppresses translation of
IFN- Cells and viruses.
Baby hamster kidney (BHK-21) cells (clone
13) were used to propagate virus stocks and to measure virus titers in
plaque assays. Secondary PK and EBK cells and IBRS2 cells were provided
by the Animal Plant and Health Inspection Service, National Veterinary Service Laboratory, Ames, Iowa, and the Foreign Animal Disease Diagnostic Laboratory, Plum Island Animal Disease Center, Greenport, N.Y. (11). Mouse EF cells derived from RNase
L
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.12.5498-5503.2001
Inhibition of L-Deleted Foot-and-Mouth Disease Virus
Replication by Alpha/Beta Interferon Involves Double-Stranded
RNA-Dependent Protein Kinase
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/
). In the present
study, we used Escherichia coli-expressed porcine and bovine IFN-
or -
individually to demonstrate that each was
equally effective in inhibiting FMDV replication. The block in FMDV
replication appeared to be at the level of protein translation,
suggesting a role for double-stranded RNA-dependent protein kinase
(PKR). In support of these findings, treatment of porcine and bovine cells with 2-aminopurine, an inhibitor of PKR, increased the yield of
virus 8.8- and 11.2-fold, respectively, compared to that in untreated
infected cells. In addition, results of FMDV infection in mouse
embryonic fibroblast cells derived from gene knockout mice lacking the
gene for RNase L
/
or PKR
/
or both
indicated an important role for PKR in the inhibition of FMDV replication.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/
)
is the first line of host cell defense against virus infection.
Virus-infected cells are induced to express and secrete IFN-
/
,
which primes neighboring cells to a virus-resistant state via a series
of events leading to activation of IFN-
/
-stimulated genes (ISGs)
(8, 26). ISGs that have been extensively
characterized include the genes for double-stranded RNA-dependent
protein kinase (PKR), 2'-5'A synthetase/RNase L, and Mx
(26, 27). The products of these genes affect viruses at
different stages of their replication cycle, and different viruses are
susceptible to different ISG products (8, 26).
/
mRNA (6, 9). It was demonstrated that FMDV
infection induces IFN-
/
mRNA synthesis but the L proteinase
inhibits cap-dependent IFN-
/
mRNA translation. The suppression of
IFN-
/
protein production allows wild-type (WT) FMDV (A12-IC) to
rapidly grow and spread in host cells, whereas a mutant FMDV lacking L
proteinase (A12-LLV2) grows poorly in cells capable of an IFN-
/
response. The inhibitory effect of IFN-
/
on FMDV is further
supported in this report. A pig kidney cell line (IBRS2), possessing
IFN-
/
genes which are not inducible by FMDV, became resistant to
both A12-IC and A12-LLV2 viruses when treated with supernatant from
secondary pig kidney (PK) cells containing IFN-
/
or with
Escherichia coli-expressed porcine IFN-
or IFN-
.
IFN-
/
treatment of IBRS2 cells resulted in a block in FMDV
protein synthesis, suggesting PKR involvement. The PKR inhibitory
effect was also demonstrated in secondary cells from target species (PK
and embryonic bovine kidney [EBK] cells) by the use of the PKR
inhibitor 2-aminopurine (2-AP). The cellular IFN-inducible
antiviral mechanism involved in the inhibition of FMDV replication was
further investigated using ISG knockout mouse embryonic fibroblast (EF)
cells. The results indicate an important role for PKR in host cell
responses to FMDV infection.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, PKR
, double-knockout, or wild-type
C57BL/6J mice lacking Mx1 (RNase L
/
,
PKR
/
, RNase L
/
PKR
/
, or
WT) were provided by Robert H. Silverman (27). RNase
L
/
PKR
/
EF cells were referred to as
triple deficient (TD) in this report since they lacked all three major
ISG components (27).
IFN-
/
PCR and RT-PCR.
PCR and reverse
transcription-PCR (RT-PCR) for IFN-
/
were performed using a
previously described RT-PCR protocol and porcine-specific primers
(6). The same primers were also used in PCR with DNA extracted from uninfected PK or IBRS2 cells to demonstrate the presence
of the IFN-
/
genes. Sets of primers designed from the 5' ends,
directly downstream of the signal sequences, and the 3' ends of porcine
and bovine IFN-
or IFN-
sequence were used in PCR to amplify
full-length IFN-
or IFN-
genes to produce constructs for E. coli expression.
E. coli-expressed porcine and bovine IFN.
mRNA
was harvested from PK or EBK cells infected with A12-LLV2 at 6 h
postinfection (hpi) and amplified by RT-PCR using IFN-
- or
-
-specific primer sets for porcine or bovine species and
Pfu DNA polymerase (Stratagene, La Jolla, Calif.) for 20 to
25 cycles. PCR products were cloned into the plasmid pCR-BluntII-TOPO
(Invitrogen, Carlsbad, Calif.) and subcloned into pET-15b (Novagen,
Madison, Wis.) downstream of a T7 promoter to produce
pET-porcine-IFN-
or -
and pET-bovine-IFN-
or -
. These
IFN-containing plasmids were sequenced to confirm specificity and used
to transform BL21(DE3)-competent bacteria for high-level T7
promoter-driven expression. The expression of IFN was induced with
isopropyl-
-D-thiogalactopyranoside (IPTG) and confirmed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
using reticulocyte lysate-expressed IFNs obtained from an in vitro
transcription and translation system (TNT kit; Promega, Madison, Wis.)
as markers. Kinetics of IPTG induction for each protein were analyzed
and the time of maximal yield was used in later experiments. These
E. coli-expressed IFNs were acid-treated to pH 2.0, neutralized, and tested for biological activity in a standard IFN assay
as described below. As a control, pET-15b containing the FMDV 3C
proteinase coding region was expressed in E. coli, treated
as above, and tested in a standard IFN assay.
IFN assay. Cells were treated with supernatant containing IFN or E. coli-expressed IFN for 16 to 24 h and then infected with A12-IC or A12-LLV2 viruses. Cells were overlaid with gum tragacanth at 1 hpi and stained for plaques at 24 to 36 hpi (6).
Northern blot hybridization.
IBRS2 cells were treated with
PK supernatant containing IFN-
/
for 16 h and infected at an
MOI of 10 with A12-IC virus. RNA was harvested at 1, 2, and 3 hpi using
an RNeasy Mini Kit (Qiagen, Valencia, Calif.) and run on a 1%
formaldehyde agarose gel. RNA was transferred to a nylon membrane,
fixed with UV light, and hybridized to a peroxidase-labeled full-length
FMDV probe from the plasmid pRMC35 (21), and
the signal was detected using a chemiluminescent technique
(4).
Radioimmunoprecipitation assay.
IBRS2 cells were treated
with PK supernatant containing IFN-
/
for 16 h and infected
at an MOI of 10 with A12-IC virus. At 0.5, 1, 1.5, 2, 2.5, and 3 hpi,
the supernatant was replaced with media without methionine for 0.5 h
and then cells were radiolabeled with [35S]methionine for
0.5 h. Cells were harvested, and the viral proteins or viral 3D
and its precursor proteins were detected in cell lysates by
radioimmunoprecipitation using a convalescent-phase serum or polyclonal
antibody against 3D, respectively, as described previously (5).
Inhibition of PKR activity by 2-AP. PK or EBK cells were mock treated or treated with 2-AP at a concentration of 10 or 3 mM, respectively, for 4 h prior to infection (12). PK or EBK cells were infected with A12-IC or A12-LLV2 at an MOI of 0.05 (based on PK or EBK titer) for 1 h and treated with 150 mM NaCl and 20 mM 2-(N-morpholino)ethanesulfonic acid (MES), pH 6.0, to inactivate free virus and then were incubated with minimum essential medium in the absence or presence of 2-AP for 24 h. Supernatant samples were collected at 1 and 24 hpi for titration on BHK-21 cells.
Virus growth in cells from ISG knockout mice.
RNase
L
/
, PKR
/
, TD, or WT EF cells were
infected with heparan sulfate binding vCRM48-KGE and vLLCRM48-KGE
viruses at an MOI of 1 (equivalent to an MOI of 0.1 in EF cells as
measured by an infective-center assay [6]). At 1 hpi,
cells were treated with MES. Viruses were harvested at 1 and 24 hpi and
titrated on BHK-21 cells, and the increase of titer over 24 h was
determined as virus growth for each cell type. Two independent
experiments were performed and the ratio of the growths of vLLCRM48-KGE
and vCRM48-KGE in each cell type was reported as a percentage.
| |
RESULTS |
|---|
|
|
|---|
Expression of porcine and bovine IFN-
and -
.
It had
previously been shown that supernatant containing porcine or bovine
IFN-
/
inhibited FMDV replication (6). To more directly study the effects of IFN-
and -
on FMDV replication, we
amplified and cloned these IFN genes from PK and EBK cells using
primers with consensus sequences specific to IFN-
and -
for each
species. A clone of each IFN was sequenced and expressed in E. coli using the pET system (Fig. 1).
At maximal induction, bovine IFN-
and -
and porcine IFN-
were
expressed at similar levels, while porcine IFN-
was expressed at
lower levels (Fig. 1). When treated at pH 2.0, serially diluted, and
tested for biological activity, porcine and bovine IFN-
or -
produced similar inhibitory effects on FMDV replication in cells from
homologous species including a pig kidney cell line (IBRS2) and EBK
cells (Table 1). However, the control
E. coli-expressed FMDV protein 3C had no inhibitory effect
on virus replication (data not shown). Expressed porcine and bovine
IFN-
or -
also had similar antiviral activities against vesicular
stomatitis virus, encephalomyocarditis virus (EMCV), and classical
swine fever virus (data not shown). In addition, we found that, unlike
bovine IFN-
, porcine and bovine IFN-
and porcine IFN-
could
inhibit FMDV replication in cells from the other species (Table 1).
|
|
Complementation of IBRS2 cells with IFN-
/
.
In cell
cultures, which produce and respond to IFN-
/
, including secondary
PK, EBK, and lamb kidney cells, A12-LLV2 infection results in slower
virus growth and yields titers lower than those of A12-IC, and the
virus is unable to form plaques (6). Here, we demonstrate
that A12-LLV2 can spread to form plaques in the pig kidney cell line
IBRS2 (Fig. 2A). To identify factors
which contribute to the difference in A12-LLV2 resistance between PK and IBRS2 cells, RNA was harvested from A12-IC, A12-LLV2, or
mock-infected cells at 6 hpi, treated with DNase I to eliminate DNA
contamination, and used in IFN-
/
RT-PCRs (Fig. 2B). DNA was also
extracted from uninfected PK and IBRS2 cells and was used to confirm
the presence of intact IFN-
/
genes. We found that both PK and
IBRS2 cells had intact IFN-
/
genes. However, upon FMDV infection, IFN-
was induced only in PK cells (Fig. 2B). Thus, the lack of IFN
mRNA expression in IBRS2 cells correlated with the ability of A12-LLV2
to form plaques in this cell line (Fig. 2A). Resistance to A12-LLV2
could be introduced into IBRS2 cells by complementing cells with
A12-LLV2-infected PK supernatant containing IFN-
/
or E. coli-expressed porcine IFN-
or -
(Fig.
3), suggesting that IBRS2 cells had a
defect in IFN-
/
induction.
|
|
Effects of IFN-
/
on FMDV RNA and protein syntheses in IBRS2
cells.
To examine the step(s) in FMDV replication affected by
IFN-
/
, IBRS2 cells were treated overnight with IFN-
/
and
infected with A12-IC. The syntheses of FMDV RNA and protein were
analyzed by Northern blot hybridization and immunoprecipitation,
respectively. In untreated IBRS2 cells, newly synthesized A12-IC
full-length RNA was initially detected between 1 and 2 hpi (Fig.
4). Treatment of IBRS2 cells with PK
supernatant containing IFN-
/
prior to A12-IC infection delayed
viral RNA synthesis to between 2 and 3 hpi, although there was still a
significant amount of viral RNA produced by 3 hpi. In
IFN-
/
-pretreated cells, production of viral protein 3D and its
precursors was both delayed from 1 or 1.5 hpi to 2 or 2.5 hpi and
significantly inhibited compared to that of mock-treated cells (Fig.
4B). Similar results were obtained using a convalescent-phase serum
that detected an array of FMDV structural and nonstructural proteins
(data not shown). Thus, in IFN-
/
-pretreated cells, the increased
amount of A12-IC RNA observed between 2 to 3 hpi was not paralleled by
an increased amount of viral protein production even up to 4 hpi. In
contrast, in the absence of IFN-
/
treatment, the increase in
viral protein production did parallel the increased amount of viral
RNA.
|
PKR effect in IFN-
/
-competent PK and EBK cells.
The
results from the IBRS2 cell experiment suggested that IFN-
/
pretreatment blocked translation of FMDV RNA, implicating a possible
role for PKR. However, priming cells overnight with IFN-
/
prior
to infection with FMDV may not accurately reflect the situation of a
viral infection in which cells are infected before IFN-
/
induction. Since A12-LLV2 infection of PK and EBK cells results in
expression and secretion of IFN-
/
, an experiment was performed
without IFN pretreatment. IFN-
/
-competent PK and EBK cells were
infected with A12-LLV2 at an MOI of 0.05 (based on the PK or EBK
titer), to allow IFN-
/
produced in initially infected cells to
induce an antiviral state in neighboring uninfected cells, and the
impact of PKR on FMDV replication was determined using the PKR
inhibitor 2-AP. Various concentrations (30, 10, and 3 mM) of 2-AP were
tested on PK and EBK cells prior to the experiments to determine the
amount that was not toxic to each cell type. PK and EBK cells were
infected in the presence or absence of 2-AP. The titers at 24 hpi
showed that 2-AP treatment at 10 and 3 mM concentrations increased the
yield of A12-LLV2 in PK and EBK cells 8.8- and 11.2-fold, respectively,
compared to the yield for untreated infected cells (from 4 × 102 to 3.5 × 103 PFU/ml in PK cells and
from 2.5 × 102 to 2.8 × 103 PFU/ml
in EBK cells). In contrast, 2-AP treatment increased the yield of
A12-IC in PK cells only 2.3-fold (from 1.9 × 105 to
4.4 × 105 PFU/ml) and did not enhance replication in
EBK cells (from 1.6 × 105 to 2.5 × 104 PFU/ml).
FMDV resistance is PKR and RNase L dependent.
To further
characterize the IFN-induced antiviral defense that is responsible for
the inhibition of FMDV replication, EF cells derived from ISG knockout
mice were infected with WT FMDV or FMDV lacking the gene for L
proteinase ("L-deleted FMDV"). Since FMDV A12 (A12-IC and
A12-LLV2), which attaches to cells via the integrin
v
3 (2, 17), could not
productively infect mouse cells, we used another pair of genetically
similar FMD viruses which attach to cells by binding to heparan sulfate
and could productively infect EF cells. The yield of WT FMDV in these
cells was approximately 104 to 105
PFU/106 cells at 24 hpi. The heparan sulfate-binding WT
FMDV (vCRM48-KGE) and its L proteinase-deleted derivative
(vLLCRM48-KGE) are chimeric viruses containing the capsid coding region
from serotype O1 Campos in A12-IC and A12-LLV2 genetic backgrounds,
respectively (1, 17, 23). The EF cells were infected with
vCRM48-KGE or vLLCRM48-KGE virus at a low MOI (see Materials and
Methods), and the yield of each virus was determined at 24 hpi. Three
types of EF cells derived from ISG knockout mice, all of which are
lacking Mx1, were used, including PKR
/
, RNase
L
/
, and TD (PKR
/
RNase
L
/
) cells (27). As expected, vLLCRM48-KGE
virus yielded a titer which was only 3% of the vCRM48-KGE virus titer
at 24 hpi in WT EF cells that contained both PKR and RNase L (Fig.
5). vLLCRM48-KGE virus yielded titers
which were 76 or 19% of vCRM48-KGE virus titers in cells which were
either PKR or RNase L deficient, respectively (Fig. 5). However, in TD
cells, both viruses grew to similar titers (the vLLCRM48-KGE titer was
91% of the vCRM48-KGE titer) (Fig. 5). These results demonstrated that
the presence of PKR significantly reduced the yield of vLLCRM48-KGE
virus, while RNase L had a lesser effect.
|
| |
DISCUSSION |
|---|
|
|
|---|
FMDV L proteinase shuts off host cap-dependent mRNA translation,
thus allowing the virus to use the host cell protein synthesis machinery with little competition (6, 7, 9, 10, 13, 15, 20,
22). In a previous report, it was demonstrated that by utilizing
this strategy, FMDV suppresses IFN-
/
protein production, resulting in rapid virus growth and spread (6). In
contrast, the infectivity of an L-deleted virus, A12-LLV2, which does
not have the ability to shut off IFN-
/
protein production, was
profoundly restricted in IFN-
/
-competent cells such as PK and EBK
cells (6).
In this study, we demonstrate that FMDV growth can be artificially
suppressed in a cell line, IBRS2, that cannot be induced to express
IFN-
/
mRNA by complementation with IFN-
/
proteins. We also
demonstrate that IFN-
of porcine or bovine origin and porcine
IFN-
could exert an inhibitory effect on FMDV in cells from
homologous and heterologous species, whereas bovine IFN-
exerted its
effect only on bovine cells.
IFN-
/
presumably inhibits FMDV by binding to the IFN-
/
receptor and initiating a series of events leading to the activation of
ISGs within these cells. The three most extensively studied ISG
components include PKR, 2'-5'A synthetase/RNase L, and Mx. EMCV,
another picornavirus, has been shown to be susceptible to the 2'-5'A
synthetase RNase L pathway (26), although a role for PKR
in the inhibition of EMCV replication was also demonstrated by
constitutive expression of human PKR in mouse cells or by experiments in EF cells derived from ISG knockout mice (16, 27).
Analysis of viral protein and RNA syntheses in infected IBRS2 cells
showed that IFN-
/
treatment significantly inhibited viral protein
synthesis even in the presence of newly synthesized viral RNA,
suggesting the involvement of PKR in translation shutoff that blocked
virus replication. A slower rate of viral RNA synthesis in
IFN-
/
-treated cells could be due either to reduced levels of the
viral RNA polymerase (3D) (demonstrated in Fig. 4B) because of
translation inhibition (possibly by PKR) or to RNA degradation by the
2'-5'A synthetase RNase L pathway. However, we have not been able to
detect FMDV RNA degradation by either Northern blot hybridization or
sucrose gradient analysis (data not shown).
Utilizing our WT and L-deleted mutant pair system, we were able to
demonstrate the significance of these ISGs in FMDV suppression in
secondary PK and EBK cells and EF cells without the need to preexpose
cells to IFN-
/
, thereby avoiding induction of ISGs prior to virus
infection. We utilized a PKR inhibitor, 2-AP, which has been shown to
inhibit activation of PKR (12). 2-AP treatment increased
the yield of L-deleted FMDV 8.8- and 11.2-fold in PK and EBK cells,
respectively. A similar result was also reported by 2-AP treatment of
HeLa cells infected with a poliovirus 2Apro mutant that,
similar to L-deleted FMDV, does not cleave eIF-4G and thus does not
shut off host protein synthesis (18). As expected, 2-AP
treatment had little or no effect on WT FMDV infection. The significance of PKR and/or 2'-5'A synthetase RNase L in the inhibition of FMDV replication was further investigated in EF cells derived from
ISG knockout mice. In this experiment, approximately 10% of cells were
initially infected and the infection continued for 24 h. We
demonstrated that IFN-
/
mRNA expression was inducible in EF cells
by WT and L-deleted FMDV infections (data not shown) and we expected to
observe the impact of ISGs in L-deleted FMDV infection because of the
translation of IFN-
/
mRNA. The yield of L-deleted FMDV was
compared to WT FMDV in a percentage format to allow a relative
quantitation of the involvement of each ISG product in the inhibition
of virus replication. In WT EF cells, L-deleted viruses grew 33-fold
more poorly than the L-expressing viruses, but in EF cells derived from
PKR gene knockout mice, the L-deleted viruses grew almost as well as
L-expressing viruses. Thus, PKR exerts a significant effect on FMDV
suppression. Similarly, the role of RNase L was examined using this
virus pair in EF cells derived from RNase L gene knockout mice, but the
impact of RNase L may not be accurately assessed in this study because
the 2'-5'A synthetase RNase L system is relatively weak in these cells
(27). Nevertheless, our results indicated that PKR and
2'-5'A synthetase RNase L were mainly responsible for the inhibition of
L-deleted FMDV replication. However, the effect of the Mx pathway on
FMDV infection could not be determined with this system.
Picornaviruses "take over" cellular macromolecular synthesis by inactivating host cap-dependent protein synthesis and utilizing viral IRES-dependent translation. Therefore, for infected TD cells, in which all of the three major ISG components are absent, we hypothesized that WT virus infection would result in higher virus yields than L-deleted virus infection because of translation competition between cellular mRNAs and viral RNAs in L-deleted virus infected cells. Surprisingly, the growth of the L-deleted virus in TD cells approached that of WT virus (Fig. 5). This suggests that translation competition has only a small inhibitory effect on the growth of the L-deleted virus in TD cells and/or that other ISGs also have only a minor role in the suppression of FMDV replication.
We have demonstrated that, in FMDV infection of cells in culture, the
main effect of host protein synthesis shutoff by the FMDV L proteinase
is the suppression of the primary antiviral response. It is apparent
that if host cells are allowed to express and secrete IFN-
/
, as
observed with L-deleted FMDV infection, then PKR and, to some degree,
2'-5'A synthetase RNase L pathways will have an inhibitory effect on
FMDV. PKR exerts its effect by phosphorylating eIF2
, thereby
inhibiting protein translation of not only host-capped mRNA but also
viral IRES-regulated mRNA.
As we have previously shown, L-deleted FMDVs are attenuated in their
natural hosts, including swine and bovines (1, 3, 5, 14).
Their attenuation appears related to the inability to block synthesis
of cytokines such as IFN-
/
due to the absence of L proteinase
activity. Thus, the identification of inhibitors of L proteinase or of
ISG products, such as PKR, may be useful in developing antiviral
strategies to block the spread and shedding of FMDV in infected animals.
| |
ACKNOWLEDGMENTS |
|---|
We thank Carole Harbison and Tracy DeMeola for assistance in
construction of IFN-
/
plasmids. We acknowledge the Animal Plant and Health Inspection Service, National Veterinary Service Laboratory, Ames, Iowa, and the Foreign Animal Disease Diagnostic Laboratory, Plum
Island Animal Disease Center, Greenport, N.Y., for EBK, PK, and IBRS2
cells; Robert H. Silverman, Aimin Zhou, and Bryan R.G. Williams,
Cleveland Clinic Foundation, for EF cells derived from knockout mice;
and Peter W. Mason, Plum Island Animal Disease Center, for
heparan sulfate-binding vCRM48-KGE and vLLCRM48-KGE viruses.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Plum Island Animal Disease Center, USDA, ARS, NAA, P.O. Box 848, Greenport, NY 11944. Phone: (631) 323-3329. Fax: (631) 323-2507. E-mail: mgrubman{at}piadc.ars.usda.gov.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Almeida, M. R., E. Rieder, J. Chinsangaram, G. Ward, C. Beard, M. J. Grubman, and P. W. Mason. 1998. Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus. Virus Res. 55:49-60[CrossRef][Medline]. |
| 2. | Berinstein, A., M. Roivainen, T. Hovi, P. W. Mason, and B. Baxt. 1995. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 69:2664-2666[Abstract]. |
| 3. |
Brown, C. C.,
M. E. Piccone,
P. W. Mason,
T. S. McKenna, and M. J. Grubman.
1996.
Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle.
J. Virol.
70:5638-5641 |
| 4. |
Chinsangaram, J.,
G. Y. Akita, and B. I. Osburn.
1994.
Detection of bovine group B rotaviruses in feces by polymerase chain reaction.
J. Vet. Diagn. Investig.
6:302-307 |
| 5. | Chinsangaram, J., P. W. Mason, and M. J. Grubman. 1998. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 16:1516-1522[CrossRef][Medline]. |
| 6. |
Chinsangaram, J.,
M. E. Piccone, and M. J. Grubman.
1999.
Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon.
J. Virol.
73:9891-9898 |
| 7. |
Devaney, M. A.,
V. N. Vakharia,
R. E. Lloyd,
E. Ehrenfeld, and M. J. Grubman.
1988.
Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex.
J. Virol.
62:4407-4409 |
| 8. |
Goodbourn, S.,
L. Didcock, and R. E. Randall.
2000.
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.
J. Gen. Virol.
81:2341-2364 |
| 9. | Grubman, M. J., and J. Chinsangaram. 2000. Foot-and-mouth disease virus: the role of the leader proteinase in viral pathogenesis. Recent Res. Dev. Virol. 2:123-134. |
| 10. | Guarne, A., J. Tormo, R. Kirchweger, D. Pfistermueller, I. Fita, and T. Skern. 1998. Structure of the foot-and-mouth disease virus leader protease: a papain-like fold adapted for self-processing and eIF4G recognition. EMBO J. 17:7469-7479[CrossRef][Medline]. |
| 11. | House, C., and J. A. House. 1989. Evaluation of techniques to demonstrate foot-and-mouth disease virus in bovine tongue epithelium: comparison of the sensitivity of cattle, mice, primary cell cultures, cryopreserved cell cultures and established cell lines. Vet. Microbiol. 20:99-109[CrossRef][Medline]. |
| 12. | Hu, Y., and T. W. Conway. 1993. 2-Aminopurine inhibits the double-stranded RNA-dependent protein kinase both in vitro and in vivo. J. Interferon Res. 13:323-328[Medline]. |
| 13. |
Kirchweger, R.,
E. Ziegler,
B. J. Lamphear,
D. Waters,
H. D. Liebig,
W. Sommergruber,
F. Sobrino,
C. Hohenadl,
D. Blaas,
R. E. Rhoads, and T. Skern.
1994.
Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma.
J. Virol.
68:5677-5684 |
| 14. | Mason, P. W., M. E. Piccone, T. S. McKenna, J. Chinsangaram, and M. J. Grubman. 1997. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 227:96-102[CrossRef][Medline]. |
| 15. | Medina, M., E. Domingo, J. K. Brangwyn, and G. J. Belsham. 1993. The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology 194:355-359[CrossRef][Medline]. |
| 16. | Meurs, E. F., Y. Watanabe, S. Kadereit, G. N. Barber, M. G. Katze, K. Chong, B. R. Williams, and A. G. Hovanessian. 1992. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66:5804-5814. |
| 17. |
Neff, S.,
D. Sa-Carvalho,
E. Rieder,
P. W. Mason,
S. D. Blystone,
E. J. Brown, and B. Baxt.
1998.
Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor.
J. Virol.
72:3587-3594 |
| 18. |
O'Neill, R. E., and V. R. Racaniello.
1989.
Inhibition of translation in cells infected with a poliovirus 2Apro mutant correlates with phosphorylation of the alpha subunit of eucaryotic initiation factor 2.
J. Virol.
63:5069-5075 |
| 19. | Piccone, M. E., E. Rieder, P. W. Mason, and M. J. Grubman. 1995. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J. Virol. 69:5376-5382[Abstract]. |
| 20. | Piccone, M. E., M. Zellner, T. F. Kumosinski, P. W. Mason, and M. J. Grubman. 1995. Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J. Virol. 69:4950-4956[Abstract]. |
| 21. |
Rieder, E.,
T. Bunch,
F. Brown, and P. W. Mason.
1993.
Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice.
J. Virol.
67:5139-5145 |
| 22. | Rueckert, R. R. 1996. Picornaviridae: the viruses and their replication, p. 609-654. In B. N. Fields, D. M. Knipe, and P. H. Howley (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 23. | Sa-Carvalho, D., E. Rieder, B. Baxt, R. Rodarte, A. Tanuri, and P. W. Mason. 1997. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 71:5115-5123[Abstract]. |
| 24. |
Strebel, K., and E. Beck.
1986.
A second protease of foot-and-mouth disease virus.
J. Virol.
58:893-899 |
| 25. |
Vakharia, V. N.,
M. A. Devaney,
D. M. Moore,
J. J. Dunn, and M. J. Grubman.
1987.
Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts.
J. Virol.
61:3199-3207 |
| 26. | Vilcek, J., and G. C. Sen. 1996. Interferons and other cytokines, p. 375-399. In B. N. Fields, D. M. Knipe, and P. H. Howley (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 27. | Zhou, A., J. M. Paranjape, S. D. Der, B. R. Williams, and R. H. Silverman. 1999. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258:435-440[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»